Literature DB >> 32111278

Treatment of the Dental Patient with Bleeding Dyscrasias: Etiologies and Management Options for Surgical Success in Practice.

Leslie R Halpern1, David R Adams2, Earl Clarkson3.   

Abstract

The oral health care provider sees a significant number of patients in his or her practice who suffer from systemic diseases affecting the ability to clot. These medical issues can be acquired or inherited bleeding dyscrasias requiring pharmacologic therapy during the perioperative period. Patients with inherited or acquired bleeding disorders require careful attention with respect to the assessment of bleeding risk. This article develops algorithms to manage acquired and inherited bleeding dyscrasias. These approaches include a discussion of the epidemiology of bleeding disorders in surgical patients, mechanism of hemostasis, and strategies for patient management based on the etiology of bleeding disorder.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticoagulants; Antiplatelet medications; Hemophilia A; Hemophilia B; Hemostatic agents; Thromboprophylaxis; von Willebrand disease

Year:  2020        PMID: 32111278     DOI: 10.1016/j.cden.2019.12.010

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  1 in total

Review 1.  Update on the management of anticoagulated and antiaggregated patients in dental practice: Literature review.

Authors:  Jesús Costa-Tort; Verónica Schiavo-Di Flaviano; Beatriz González-Navarro; Enric Jané-Salas; Albert Estrugo-Devesa; José López-López
Journal:  J Clin Exp Dent       Date:  2021-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.